Profile
Dr Tan Hiang Keat is a Senior Consultant with the Department of Gastroenterology & Hepatology. His subspecialties are Viral Hepatitis, Liver Cirrhosis and Portal Hypertension.
He is also a Clinical Tutor at the Yong Loo Lin Schoo of Medicine, National University of Singapore.
Education
- MBBS: NUS, 2003
- MRCP: Edinburgh, 2007
- Basic Specialist Training in Internal Medicine: Joint Committee of Specialist Training, Ministry of Health Singapore, 2007
- Certificate of Specialist Accreditation (Gastroenterology): Specialist Accreditation Board, Ministry of Health Singapore, 2011
View More +
Professional Appointments and Committee Memberships
View More +
Awards
- Best Registrar Award, SingHealth: 2011
- Dean's List Award for Second Professional Examination (Part III), National University of Singapore: 2002
- Dean's List Award for Second Professional Examination (Part I), National University of Singapore: 2000
- Dean's List Award for First Professional Examination, National University of Singapore, 1999
View More +
Publications
Paper/Poster Presentations
- Acute-on-Chronic Liver Failure in a Tertiary Centre in Singapore (Free paper), Asian Pacific Digestive Week, 2011
- Role of the EUS in the Diagnosis and Management of Intermediate Pancreatic Cysts (Free paper), Digestive Disease Week, 2011
- EUS and Pancreatic Cysts Fluid Analysis in Predicting Potentially Malignant or Malignant Cystic Lesions of the Pancreas (Oral symposium), United European Gastroenterology Week, 2010
Research Projects
- 2011: Identification of novel biomarkers to refine early HCC detection and to enable the molecular stratification of HCC patients for optimized personalized treatment (Co-investigator)
- 2011: Prospective validation of transient elastography with XL probe for the evaluation of hepatic fibrosis in Asians with normal and elevated body mass index (Co-investigator)
- 2010: Dose ranging study to evaluate the safety, efficacy of pegylated interferon lambda (BMS-914143) monotherapy in interferon naïve patients with chronic hepatitis B virus infection who are HBeAg-positive (Co-investigator II)
- 2009: An open-label, randomized study to evaluate the acute immunologic responses in Asian subjects with E antigen positive Chronic Hepatitis B following initiation of therapy of Hepatitis B with Pegasys, Nucleoside analogues, or both (Co-investigator I)
- 2009: An Open-label, Multi-center Protocol to observe the Effects of Pegylated Interferon Alfa-2a (PEGASYS ®) as Monotherapy in patients with Chronic Hepatitis B who have participated in Previous Roche or Roche Partner protocols (Co-investigator I)
View More +